+
Site Tour

EuroPCR 2023: Pivotal momentum for tricuspid valve intervention

Fabien Praz chairs this panel discussion on the pivotal momentum for tricuspid valve intervention. He is joined by Christian Besler, Phillipp Lurz, Paul Sorajja and Nina Wunderlich.

Related Videos

EuroPCR 2023: Vascular access

EuroPCR 2023: COAPT 5-year follow-up

EuroPCR 2023: Defining the future

EuroPCR 2023: Mitral regurgitation

Review the Trends | Mitral focus

Navigating the Anatomy | Tricuspid focus

SAFETY IS A JOURNEY | M. Swaans & G. Leurent

AV VALVES 2023: TA, TF in TMVR

AV VALVES 2023: Trending Topics – Complexity

TriClip™: Clinical evidence

Javier's testimonial

Case Parade | Tricuspid focus

TRENDING TOPICS

TAVI Webinar 1- Key learnings for advanced TAVI

TAVI Webinar 1- when the present unlocks the future:key learnings for advances TAVI

Treating Large annuli with 35mm Navitor Vision

Achieving optimal outcomes for treatment of large annuli with 35 mm Navitor Vision Valve

PCR Webinar on secondary mitral regurgitation

New evidence reshaping the management of secondary mitral regurgitation

CONNEXT


HUB
RELATED RESOURCES

ESC 2021: HF & VHD Guidelines

2-year outcomes from the TRILUMINATE Pivotal trial

bRIGHT study

CONNEXT


LIVE
RELATED EVENTS

AV VALVES 2023: HoloLens Technology

Review the Trends | Mitral focus

EuroPCR 2023: Tricuspid valve

SAFETY IS A JOURNEY | J. Van der Heyden & C. Besler

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline